Covered recipient · General Payments record
DAPHNE BEENE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$902.57
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $699.04 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $265.50 | 13 |
| Vanda Pharmaceuticals Inc. | $182.25 | 6 |
| Braeburn Inc. | $102.17 | 4 |
| Alkermes, Inc. | $57.82 | 2 |
| Supernus Pharmaceuticals, Inc. | $34.74 | 2 |
| Gilead Sciences, Inc. | $21.81 | 1 |
| Axsome Therapeutics, Inc. | $18.10 | 1 |
| Indivior Inc. | $16.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $78.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505753 | CMS |
| ABBVIE INC. | $11.36 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505755 | CMS |
| ABBVIE INC. | $28.41 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505757 | CMS |
| ABBVIE INC. | $5.71 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505759 | CMS |
| ABBVIE INC. | $13.72 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505761 | CMS |
| ABBVIE INC. | $12.35 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505763 | CMS |
| ABBVIE INC. | $17.36 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505765 | CMS |
| ABBVIE INC. | $13.93 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505767 | CMS |
| ABBVIE INC. | $6.11 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505769 | CMS |
| ABBVIE INC. | $8.26 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505771 | CMS |
| ABBVIE INC. | $23.64 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505773 | CMS |
| ABBVIE INC. | $22.16 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505775 | CMS |
| ABBVIE INC. | $24.07 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505777 | CMS |
| Alkermes, Inc. | $24.86 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120465061 | CMS |
| Alkermes, Inc. | $32.96 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120465063 | CMS |
| Axsome Therapeutics, Inc. | $18.10 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148352202 | CMS |
| Braeburn Inc. | $25.66 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612339 | CMS |
| Braeburn Inc. | $20.98 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612341 | CMS |
| Braeburn Inc. | $27.02 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612343 | CMS |
| Braeburn Inc. | $28.51 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612345 | CMS |
| Gilead Sciences, Inc. | $21.81 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133689994 | CMS |
| Indivior Inc. | $16.65 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544037 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.37 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147899928 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.37 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147899930 | CMS |
| Vanda Pharmaceuticals Inc. | $24.09 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931094 | CMS |
| Vanda Pharmaceuticals Inc. | $11.94 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931096 | CMS |
| Vanda Pharmaceuticals Inc. | $18.53 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931098 | CMS |
| Vanda Pharmaceuticals Inc. | $78.15 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931100 | CMS |
| Vanda Pharmaceuticals Inc. | $22.90 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931102 | CMS |
| Vanda Pharmaceuticals Inc. | $26.64 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931104 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.